115 related articles for article (PubMed ID: 35822500)
21. Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo.
Bouvy C; Wannez A; Laloy J; Chatelain C; Dogné JM
Leuk Res; 2017 Nov; 62():70-76. PubMed ID: 28987820
[TBL] [Abstract][Full Text] [Related]
22. Expression of TRAIL (Apo2L), DR4 (TRAIL receptor 1), DR5 (TRAIL receptor 2) and TRID (TRAIL receptor 3) genes in multidrug resistant human acute myeloid leukemia cell lines that overexpress MDR 1 (HL60/Tax) or MRP (HL60/AR).
Kim CH; Gupta S
Int J Oncol; 2000 Jun; 16(6):1137-9. PubMed ID: 10811986
[TBL] [Abstract][Full Text] [Related]
23. Antiproliferative effect of ZSTK474 alone or in combination with chemotherapeutic drugs on HL60 and HL60/ADR cells.
Zhou Q; Chen Y; Zhang L; Zhong Y; Zhang Z; Wang R; Jin M; Gong M; Qiu Y; Kong D
Oncotarget; 2017 Jun; 8(24):39064-39076. PubMed ID: 28388564
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of Mcl-1 confers multidrug resistance, whereas topoisomerase IIβ downregulation introduces mitoxantrone-specific drug resistance in acute myeloid leukemia.
Hermanson DL; Das SG; Li Y; Xing C
Mol Pharmacol; 2013 Aug; 84(2):236-43. PubMed ID: 23696245
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of catalase gene expression in the doxorubicin-resistant AML subline AML-2/DX100.
Kim HS; Lee TB; Choi CH
Biochem Biophys Res Commun; 2001 Feb; 281(1):109-14. PubMed ID: 11178967
[TBL] [Abstract][Full Text] [Related]
26. Effect of ST3GAL 4 and FUT 7 on sialyl Lewis X synthesis and multidrug resistance in human acute myeloid leukemia.
Ma H; Zhou H; Li P; Song X; Miao X; Li Y; Jia L
Biochim Biophys Acta; 2014 Sep; 1842(9):1681-92. PubMed ID: 24953795
[TBL] [Abstract][Full Text] [Related]
27. Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells.
Côme MG; Skladanowski A; Larsen AK; Laurent G
Br J Cancer; 1999 Mar; 79(7-8):1090-7. PubMed ID: 10098741
[TBL] [Abstract][Full Text] [Related]
28. The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines.
Batova A; Shao LE; Diccianni MB; Yu AL; Tanaka T; Rephaeli A; Nudelman A; Yu J
Blood; 2002 Nov; 100(9):3319-24. PubMed ID: 12384433
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of LncRNA CRNDE suppresses proliferation and P-glycoprotein-mediated multidrug resistance in acute myelocytic leukemia through the Wnt/β-catenin pathway.
Kang Y; Zhang S; Cao W; Wan D; Sun L
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32426817
[TBL] [Abstract][Full Text] [Related]
30. Double-edged sword of chemosensitizer: increase of multidrug resistance protein (MRP) in leukemic cells by an MRP inhibitor probenecid.
Kim HS; Min YD; Choi CH
Biochem Biophys Res Commun; 2001 Apr; 283(1):64-71. PubMed ID: 11322768
[TBL] [Abstract][Full Text] [Related]
31. Cell-specific modulation of drug resistance in acute myeloid leukemic blasts by diphtheria fusion toxin, DT388-GMCSF.
Frankel AE; Hall PD; McLain C; Safa AR; Tagge EP; Kreitman RJ
Bioconjug Chem; 1998; 9(4):490-6. PubMed ID: 9667951
[TBL] [Abstract][Full Text] [Related]
32. B4GALT family mediates the multidrug resistance of human leukemia cells by regulating the hedgehog pathway and the expression of p-glycoprotein and multidrug resistance-associated protein 1.
Zhou H; Ma H; Wei W; Ji D; Song X; Sun J; Zhang J; Jia L
Cell Death Dis; 2013 Jun; 4(6):e654. PubMed ID: 23744354
[TBL] [Abstract][Full Text] [Related]
33. Radiation and heat sensitivity of human T-lineage acute lymphoblastic leukemia (ALL) and acute myeloblastic leukemia (AML) clones displaying multiple drug resistance (MDR).
Uckun FM; Mitchell JB; Obuz V; Chandan-Langlie M; Min WS; Haissig S; Song CW
Int J Radiat Oncol Biol Phys; 1992; 23(1):115-25. PubMed ID: 1572809
[TBL] [Abstract][Full Text] [Related]
34. HOTAIR suppresses PTEN via DNMT3b and confers drug resistance in acute myeloid leukemia.
Zhou W; Xu S; Chen X; Wang C
Hematology; 2021 Dec; 26(1):170-178. PubMed ID: 33538241
[TBL] [Abstract][Full Text] [Related]
35. Antitumour effects of selected plant polyphenols, gallic acid and ellagic acid, on sensitive and multidrug-resistant leukaemia HL60 cells.
Maruszewska A; Tarasiuk J
Phytother Res; 2019 Apr; 33(4):1208-1221. PubMed ID: 30838722
[TBL] [Abstract][Full Text] [Related]
36. Drug-resistance enables selective killing of resistant leukemia cells: exploiting of drug resistance instead of reversal.
Blagosklonny MV
Leukemia; 1999 Dec; 13(12):2031-5. PubMed ID: 10602425
[TBL] [Abstract][Full Text] [Related]
37. Grape seed proanthocyanidin extract reverses multidrug resistance in HL-60/ADR cells via inhibition of the PI3K/Akt signaling pathway.
Lin KN; Jiang YL; Zhang SG; Huang SY; Li H
Biomed Pharmacother; 2020 May; 125():109885. PubMed ID: 32007917
[TBL] [Abstract][Full Text] [Related]
38. The role of bioreductive activation of antitumour anthracycline drugs in cytotoxic activity against sensitive and multidrug resistant leukaemia HL60 cells.
Kostrzewa-Nowak D; Bieg B; Paine MJ; Wolf CR; Tarasiuk J
Eur J Pharmacol; 2012 Jan; 674(2-3):112-25. PubMed ID: 22115891
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway.
Zhang Y; Liu Y; Xu X
J Cell Biochem; 2018 Jul; 119(7):6296-6308. PubMed ID: 29663500
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of harringtonine-resistant human leukemia HL60 cell.
He QY; Zhou WD; Ji L; Zhang HQ; He NG; Xue SB
Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):463-7. PubMed ID: 9863176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
